Ann: Quarterly Activities & Cashflow Report, page-3

First 3 Last

Share
Profile

Follow
rt168

349 Posts.

27

30/07/19

10:10

Post #: 39753773
Share

Originally posted by Sharetrader78: ↑

What I take from the Qty report>>

And doesn't this can sum up EAR forward plan for 2H19
• Strong cash position of $17.3 million at 30 June 2019 to support upcoming exploration and growth activities ..... ?

what about moving into production towards some 300mill free cashflow over 4yrs from the first stage BFS backed??!!

And actually, become a Gold Producer as we have heard since MKO first acquired the BZW that of course reverse T/O to EAR this was stated the best plan to see BFS =funding = Production months ago..(Is it not a bankable study !!)

I feel the plan now is to continue as an Explorer till EAR looks so undervalued that NST will take us out for a fair value we hope

Also Admin/wages over 2mill for the Qtr ? pretty high for an mgmt team that isn't doing much outside re-releasing minor modified BFS and organizing exploration and funding to keep the FAT wages flowing into their pockets ..

Is the truth that EAR Mgmt plan is to be T/O by NST but first milking Fat incomes and perks (roadshows to Noosa) continue to pump funds into exploring areas NST needs more clarity on their nearby Projects(But far from BZW) before making a move ... I do see next Est Qtr Admin/staff costs down to just over 1mill .. one positive I can take away ..

I see CMM another WA Gold explorer + hopeful future producer (also hold but going to exit) has a 40mill higher market value ... zero Gold plant unlikely to see any Gold sales for many many Qtrs but as they have a new MD with a history of taking projects into successive mining operations BOOM TIME

And isn't that the true reason why EAR isn't 40c+ right now as the market just can't trust the guys in charge that they really plan or want to make $$$ anytime soon ... even though we have all of the indigents

Expand

You need a lot of hours to organise an epic junket to Noosa mate...

But in all seriousness, only reason I am still holding is waiting for our overlord to takes us over. Otherwise, based on management's ambition and pedigree, I would have deployed capital elsewhere.

EAR Price at posting: 20.0¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

As Nvidia cools, we're looking to Aussie AI

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

There are more pages in this discussion • 34 more messages in this thread...

First 3 Last

Add EAR (ASX) to my watchlist

Ann: Quarterly Activities & Cashflow Report, page-3

Top Stories

Shekel Brainweigh investor presentation webinar – the future of retail automation

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

As Nvidia cools, we're looking to Aussie AI

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Featured News